COVID – 19 | Vaccination Update – Day 626

ad
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

India’s COVID-19 vaccination coverage has crossed 218.79 Crore (2,18,79,83,976) today. More than 2 lakh (2,67,065) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10415228
2nd Dose 10119117
Precaution Dose 7033212
FLWs 1st Dose 18436859
2nd Dose 17716887
Precaution Dose 13668698
Age Group 12-14 years 1st Dose 41044245
  2nd Dose 31836159
Age Group 15-18 years 1st Dose 61950702
  2nd Dose 53099672
Age Group 18-44 years 1st Dose 561300808
2nd Dose 515872956
Precaution Dose 96802431
Age Group 45-59 years 1st Dose 204034401
2nd Dose 196985699
Precaution Dose 49235139
Over 60 years 1st Dose 127672140
2nd Dose 123155886
Precaution Dose 47603737
Cumulative 1st dose administered 1024854383
Cumulative 2nd dose administered 948786376
Precaution Dose 214343217
Total 2187983976

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 2nd October, 2022 (626th Day)
HCWs 1st Dose 1
2nd Dose 58
Precaution Dose 1080
FLWs 1st Dose 10
2nd Dose 89
Precaution Dose 2688
Age Group 12-14 years 1st Dose 3013
  2nd Dose 8883
Age Group 15-18 years 1st Dose 1024
  2nd Dose 3494
Age Group 18-44 years 1st Dose 4928
2nd Dose 14206
Precaution Dose 141977
Age Group 45-59 years 1st Dose 797
2nd Dose 2852
Precaution Dose 53348
Over 60 years 1st Dose 531
2nd Dose 2311
Precaution Dose 25775
Cumulative 1st dose administered 10304
Cumulative 2nd dose administered 31893
Precaution Dose 224868
Total 267065

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply